BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9775281)

  • 1. Interpreting measures of treatment effect.
    Davies HT
    Hosp Med; 1998 Jun; 59(6):499-501. PubMed ID: 9775281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistics review 11: assessing risk.
    Bewick V; Cheek L; Ball J
    Crit Care; 2004 Aug; 8(4):287-91. PubMed ID: 15312212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Using "number needed to treat" to interpret treatment effect].
    Ke DS
    Acta Neurol Taiwan; 2006 Jun; 15(2):120-6. PubMed ID: 16871900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Communicating the benefits and harms of treatments.
    Akobeng AK
    Arch Dis Child; 2008 Aug; 93(8):710-3. PubMed ID: 18456681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measures of association in clinical trials: definition and interpretation.
    Carneiro AV
    Rev Port Cardiol; 2003 Nov; 22(11):1393-401. PubMed ID: 14768494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based dermatology: number needed to treat and its relation to other risk measures.
    Manriquez JJ; Villouta MF; Williams HC
    J Am Acad Dermatol; 2007 Apr; 56(4):664-71. PubMed ID: 17367615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk and prevention in cardiovascular diseases].
    Gulácsi L; Edes I; Hajdú E; Tóthfalusi L
    Orv Hetil; 2004 Dec; 145(50):2515-21. PubMed ID: 15662751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linking evidence-based medicine therapeutic summary measures to clinical decision analysis.
    Djulbegovic B; Hozo I; Lyman GH
    MedGenMed; 2000 Jan; 2(1):E6. PubMed ID: 11104452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding results.
    Breau RH; Dahm P; Fergusson DA; Hatala R
    J Urol; 2009 Mar; 181(3):985-92. PubMed ID: 19150555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding measures of treatment effect in clinical trials.
    Akobeng AK
    Arch Dis Child; 2005 Jan; 90(1):54-6. PubMed ID: 15613512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interpretation of absolute measures of disease risk in comparative research.
    Replogle WH; Johnson WD
    Fam Med; 2007 Jun; 39(6):432-5. PubMed ID: 17549653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative vs. absolute measures of benefit and risk: what's the difference?
    Citrome L
    Acta Psychiatr Scand; 2010 Feb; 121(2):94-102. PubMed ID: 19694632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells.
    Rücker G; Schwarzer G; Carpenter J; Olkin I
    Stat Med; 2009 Feb; 28(5):721-38. PubMed ID: 19072749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis: when and how.
    Imperiale TF
    Hepatology; 1999 Jun; 29(6 Suppl):26S-31S. PubMed ID: 10386080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Concepts important in the interpretation of therapeutic studies. Absolute risk reduction (ARR), relative risk reduction (RRR), number needed to treat (NNT)].
    Steurer J
    Praxis (Bern 1994); 1997 Apr; 86(15):614. PubMed ID: 9213913
    [No Abstract]   [Full Text] [Related]  

  • 17. What is evidence-based medicine and why should I care?
    Hess DR
    Respir Care; 2004 Jul; 49(7):730-41. PubMed ID: 15222906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Number-needed-to-treat (NNT)--needs treatment with care.
    Christensen PM; Kristiansen IS
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):12-6. PubMed ID: 16867164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tips for learners of evidence-based medicine: 1. Relative risk reduction, absolute risk reduction and number needed to treat.
    Barratt A; Wyer PC; Hatala R; McGinn T; Dans AL; Keitz S; Moyer V; For GG;
    CMAJ; 2004 Aug; 171(4):353-8. PubMed ID: 15313996
    [No Abstract]   [Full Text] [Related]  

  • 20. Relative risk, absolute risk and number needed to treat: basic concepts.
    Carneiro AV
    Rev Port Cardiol; 2009 Jan; 28(1):83-7. PubMed ID: 19388495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.